New Insights for Oxidative Stress and Diabetes Mellitus

Kenneth Maiese1

  • 1Laboratory of Cellular and Molecular Signaling, Newark, NJ 07101, USA.

Insights

Oxidative stress contributes to diabetes mellitus (DM). Targeting pathways like mTOR, SIRT1, and WISP1 may offer new therapies for DM by addressing stem cells, energy, and vascular issues.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Endocrinology

Background:

  • Oxidative stress and reactive oxygen species (ROS) play a critical role in the pathogenesis of diabetes mellitus (DM).
  • The increasing prevalence of DM necessitates novel therapeutic strategies to mitigate the harmful effects of oxidative stress.
  • Understanding the intricate molecular pathways involved in DM is crucial for developing effective treatments.

Purpose of the Study:

  • To identify and evaluate key molecular targets for novel diabetes mellitus (DM) therapies.
  • To explore the potential of mechanistic target of rapamycin (mTOR), silent mating type information regulation 2 homolog 1 (SIRT1), and Wnt1 inducible signaling pathway protein 1 (WISP1) as therapeutic targets for DM.
  • To investigate the complex interplay between cellular pathways and DM progression.

Main Methods:

  • Literature review and pathway analysis focusing on mTOR, SIRT1, and WISP1 in the context of DM.
  • Examination of the relationship between these pathways and stem cell function, glucose tolerance, apoptosis, autophagy, tissue remodeling, energy homeostasis, and vascular biology.
  • Assessment of the proliferative nature of identified pathways for therapeutic development.

Main Results:

  • The mechanistic target of rapamycin (mTOR), silent mating type information regulation 2 homolog 1 (SIRT1), and Wnt1 inducible signaling pathway protein 1 (WISP1) pathways are implicated in critical aspects of DM.
  • These pathways influence stem cell behavior, glucose metabolism, programmed cell death (apoptosis and autophagy), tissue repair, energy balance, and vascular health in DM.
  • Understanding the proliferative characteristics of these pathways is key to their therapeutic application.

Conclusions:

  • Targeting mTOR, SIRT1, and WISP1 pathways presents a promising therapeutic avenue for managing diabetes mellitus (DM).
  • Further research into these pathways can lead to the development of effective treatments that address the multifaceted nature of DM.
  • Translating this knowledge into clinical practice requires a thorough understanding of pathway dynamics to optimize efficacy and minimize side effects.

Related Concept Videos

Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
645
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.5K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
6.2K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.8K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.9K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
15.1K